Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to demonstrate that epoetin alfa treatment reduces the proportion of anemic subjects with International Prognostic Scoring Systems (IPSS) Low or Intermediate 1 risk myelodysplastic syndromes (MDS) who require any transfusion, compared with placebo, through Week 48.
Inclusion criteria
- IPSS Low or Intermediate 1 RISK Myelodysplastic Syndromes at risk for transfusion